«JSC «Rafarma»

Established in 2006

JSC “Rafarma” is an integrated pharmaceutical production site designed and operating in compliance with the requirements of the GMP EU. “Rafarma” project is an implementation of the Strategy “Pharma 2020”. It is on the List of perspective projects in the pharmaceutical and medical industry of Ministry of Industry and Trade RF.

Innovative research and manufacturing site is located in Terbuny village of Lipetsk Region. The total production area is 25,000 sqm. In addition, production plant for light-duty batches of API and solid forms is located at the Institute of Problems of Chemical Physics of RAS in Chernogolovka of Moscow Region.

In the company's own product portfolio, 16 items of high-tech medicines from the list of VED are antibiotics, cytostatics, oral hypoglycemic drugs, cardiovascular, antituberculous and other drugs in 15 medicinal forms.        

Integrated manufacturing cycle of cephalosporins, antibiotics non-β-lactam, antineoplastics and medicines of other pharmacological groups is carried out in 5 separate sections. They are equipped with closed water-treatment systems and closed-circuit ventilation.

Home based R&D facilities carry out autonomous research activities and develop original medicines. The pilot plant is located in the Category “D” rooms to develop industrial prototypes of medicines for clinical trials and pharmacological monitoring, scale R&D developments and work out the technology for industrial production of new products.


Equipment manufactured by major European companies is installed at “Rafarma” facilities to produce almost all dosage forms of medicines. Manufacturing capacity (per year): 1.33 billion tablets, 280 million hard gelatin capsules, 54 million injection vials, 18 million sachets, 7 million packs of ointments, gels, suppositories, 1.35 million packs of lyophilizates, 220 kg of chemical synthesis substances.


сотекс Рафарма протеин протек транссервис
спарго протек-свм ригла протек фонд
Проаптека